Zhendong Pharmacy(300158.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Zhendong Pharmacy
300158.SZ
Shanxi Zhendong Pharmaceutical Co.,Ltd, together with its subsidiaries, engages in the research, development, production, and sales of pharmaceutical drugs in China. It offers drugs for various fields, including tumors, dermatology, digestion, urology, and cardio-cerebral drugs. The company also provides Chinese herbal medicines. Shanxi Zhendong Pharmaceutical Co.,Ltd was founded in 1995 and is based in Changzhi, China.
2.805 T
300158.SZMarket value -Rank by Market Cap -/-

Financial Score

19/05/2026 Update
C
PharmaceuticalsIndustry
Industry Ranking130/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-8.65%D
    • Profit Margin-11.33%D
    • Gross Margin53.73%B
  • Growth ScoreD
    • Revenue YoY-9.03%D
    • Net Profit YoY77.54%A
    • Total Assets YoY-3.48%D
    • Net Assets YoY-8.70%D
  • Cash ScoreC
    • Cash Flow Margin143.28%B
    • OCF YoY-9.03%D
  • Operating ScoreB
    • Turnover0.59B
  • Debt ScoreB
    • Gearing Ratio26.04%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    00:35 ETSky Labs bringt „CART ON" auf den Markt, die weltweit erste ringförmige, tragbare Blutdrucküberwachungslösung für Krankenhausabteilungen

    prnewswire·
    SH
    513700
    -1.06%
    US
    XBI
    -0.69%
    SH
    512010
    -1.43%
    prnewswire·
    SH
    513700
    -1.06%
    US
    XBI
    -0.69%
    SH
    512010
    -1.43%

    Zhendong Pharmacy established a refined wall-breaking decoction pieces technology company

    Zhitong·
    SZ
    300158
    -2.11%
    Zhitong·
    SZ
    300158
    -2.11%

    Zhendong Pharmacy released its performance for the first three quarters, with a net profit attributable to the parent company of 20.3641 million yuan, a decrease of 49.25%

    Zhitong·
    SZ
    300158
    -2.11%
    Zhitong·
    SZ
    300158
    -2.11%

    Innovative drug concept stocks fell in the afternoon, with Staidson BioPharm down over 10%

    Zhitong·
    SZ
    002940
    -8.91%
    SZ
    300158
    -2.11%
    SZ
    300204
    -1.12%
    Zhitong·
    SZ
    002940
    -8.91%
    SZ
    300158
    -2.11%
    SZ
    300204
    -1.12%

    Zhendong Pharmacy: Adjusting the upper limit of the repurchase price to RMB 11.40 per share

    Zhitong·
    SZ
    300158
    -2.11%
    Zhitong·
    SZ
    300158
    -2.11%
    © 2026 Longbridge｜Disclaimer